Use of nivolumab for colon cancer with Lynch syndrome
Lynch syndrome (LS), which occurs as a result of the defects in DNA mismatch repair, is characterized by an increased risk of colon, endometrial and urinary tract cancers. It is known that in case of colorectal cancer, the presence of high-frequency microsatellite instability (MSI-H) is associated w...
Saved in:
Main Authors: | G. A. Khakimov, A. A. Tryakin, G. G. Khakimova |
---|---|
Format: | article |
Language: | RU |
Published: |
IP Habib O.N.
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/b99da209ccc44f37985e2d2943ad2e92 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
by: Terufumi Yoshida, et al.
Published: (2021) -
New targeted treatments for non-small-cell lung cancer – role of nivolumab
by: Zago G, et al.
Published: (2016) -
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
by: Elena A. Demina
Published: (2021) -
The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
by: Maria V. Deligiorgi, et al.
Published: (2021) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
by: Seetharamu N, et al.
Published: (2017)